Company · CIK 0001785279 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Metagenomi Therapeutics, Inc. · MGX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 PForm 4 → | Sep 11, 7:51 pm EDT | Laurence ReidDirector | 20,000 | $1.17 | $23,401 | 20,000 | — | |
| Sep 8, 2026 SForm 4 → | Sep 10, 3:47 pm EDT | Matthew WeinSee Remarks | 358 | $1.16 | $415 | 126,133 | −0.28% | |
| Sep 8, 2026 SForm 4 → | Sep 10, 3:40 pm EDT | Jian IrishSee Remarks, Director | 2,140 | $1.16 | $2,479 | 375,393 | −0.57% | |
| Sep 8, 2026 SForm 4 → | Sep 10, 3:34 pm EDT | Pamela WapnickChief Financial Officer | 1,911 | $1.16 | $2,214 | 206,580 | −0.92% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.